Search Results - "Kakkis, E.D."

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Identification and molecular characterization of α‐L‐iduronidase mutations present in mucopolysaccharidosis type I patients undergoing enzyme replacement therapy by Yogalingam, G., Guo, X.‐H., Muller, V.J., Brooks, D.A., Clements, P.R., Kakkis, E.D., Hopwood, J.J.

    Published in Human mutation (01-09-2004)
    “…Mucopolysaccharidosis type I (MPS I) is an autosomal recessive lysosomal storage disorder caused by a deficiency of α‐L‐iduronidase (IDUA). Mutations in the…”
    Get full text
    Journal Article
  2. 2

    Continuous infusion of enzyme replacement therapy is inferior to weekly infusions in MPS I dogs by Passage, M. B., Krieger, A. W., Peinovich, M. C., Lester, T., Le, S. Q., Dickson, P. I., Kakkis, E. D.

    Published in Journal of inherited metabolic disease (01-12-2009)
    “…Summary Intravenous enzyme replacement therapy with recombinant human α- l -iduronidase (rhIDU) is used weekly to treat mucopolysaccharidosis (MPS) I. We…”
    Get full text
    Journal Article
  3. 3

    Enzyme Replacement Therapy in Feline Mucopolysaccharidosis I by Kakkis, E.D., Schuchman, E., He, X., Wan, Q., Kania, S., Wiemelt, S., Hasson, C.W., O'Malley, T., Weil, M.A., Aguirre, G.A., Brown, D.E., Haskins, M.E.

    Published in Molecular genetics and metabolism (01-03-2001)
    “…Enzyme replacement therapy (ERT) has long been considered an approach to treating lysosomal storage disorders caused by deficiency of lysosomal enzymes. ERT is…”
    Get full text
    Journal Article
  4. 4

    Penetration, diffusion, and uptake of recombinant human α- l-iduronidase after intraventricular injection into the rat brain by Belichenko, P.V., Dickson, P.I., Passage, M., Jungles, S., Mobley, W.C., Kakkis, E.D.

    Published in Molecular genetics and metabolism (01-09-2005)
    “…Central nervous system disease can have devastating consequences in the severe or Hurler form of mucopolysaccharisosis I (MPS I). Intravenously administered…”
    Get full text
    Journal Article
  5. 5

    Enzyme replacement in a canine model of Hurler syndrome by Shull, R.M. (University of Tennessee, Knoxville, TN.), Kakkis, E.D, McEntee, M.F, Kania, S.A, Jonas, A.J, Neufeld, E.F

    “…The Hurler syndrome (alpha-L-iduronidase deficiency disease) is a severe lysosomal storage disorder that is potentially amenable to enzyme-replacement therapy…”
    Get full text
    Journal Article
  6. 6

    Overexpression of the human lysosomal enzyme alpha-L-iduronidase in Chinese hamster ovary cells by Kakkis, E D, Matynia, A, Jonas, A J, Neufeld, E F

    Published in Protein expression and purification (01-06-1994)
    “…We developed a Chinese hamster ovary (CHO) cell line that produces and secretes large quantities of recombinant human alpha-L-iduronidase, the lysosomal…”
    Get more information
    Journal Article